Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effect of extraction vehicles on medical device sensitization testing by LuSens assay.

Toxicology in vitro : an international journal published in association with BIBRA·2025
Same author

Vascular Damage and Repair - Are Small-Diameter Vascular Grafts Still the "Holy Grail" of Tissue Engineering?

Physiological research·2024
Same author

Health safety of parabens evaluated by selected in vitro methods.

Regulatory toxicology and pharmacology : RTP·2022
Same author

Comparison of methods used for evaluation of mutagenicity/genotoxicity of model chemicals - parabens.

Physiological research·2021
Same author

Safety testing of adult novelties using in vitro methods.

Regulatory toxicology and pharmacology : RTP·2020
Same author

Advanced characterization of natural biofilm on nanofiber scaffold.

Physiological research·2020
Same journal

The personality of professor Otakar Štark in the context of the development of medical genetics in Czechoslovakia in the years 1950-1990.

Casopis lekaru ceskych·2026
Same journal

Václav Náprstek, MD - a forgotten hero.

Casopis lekaru ceskych·2026
Same journal

Professor Otto Piffl, the First Full Professor of Otology and Rhinology at the German University in Prague, passed away 100 years ago.

Casopis lekaru ceskych·2026
Same journal

Ancient sanctuary of Eileithyia, goddess of childbirth, on the island of Paros (Greece).

Casopis lekaru ceskych·2026
Same journal

European Partnership for Personalised Medicine (EP PerMed).

Casopis lekaru ceskych·2026
Same journal

Periodontitis and type 2 diabetes.

Casopis lekaru ceskych·2026
See all related articles

Related Experiment Videos

[Cryptogenic fibrotizing alveolitis].

L Svobodová1, J Homolka

  • 1I. klinika tuberkulózy a respiracních nemocí 1. LF UK a VFN, Praha. lenka.svobodova@vfn.cz

Casopis Lekaru Ceskych
|February 9, 2008
PubMed
Summary
This summary is machine-generated.

This article explores cryptogenic fibrosing alveolitis (CFA), detailing its causes, histological types, and clinical presentation. It outlines diagnostic approaches and treatment options, including anti-inflammatory therapies and lung transplantation for this interstitial lung disease.

Related Experiment Videos

Area of Science:

  • Pulmonology
  • Pathology

Context:

  • Cryptogenic fibrosing alveolitis (CFA) is a progressive interstitial lung disease with significant morbidity.
  • Accurate diagnosis and timely management are crucial for patient outcomes.

Purpose:

  • To provide a comprehensive overview of cryptogenic fibrosing alveolitis (CFA).
  • To detail the pathogenesis, histological classifications, clinical features, and diagnostic strategies for CFA.
  • To discuss current and emerging therapeutic interventions for CFA.

Summary:

  • The article elucidates the pathogenesis and distinct histological subtypes of CFA based on ATS and ERS criteria.
  • It outlines the clinical picture of CFA and recommends a structured examination program.
  • Management strategies discussed include anti-inflammatory/immunosuppressive treatments, home oxygen therapy, lung transplantation, and pulmonary hypertension management.

Impact:

  • This review aims to enhance understanding of CFA among clinicians.
  • It provides a framework for improved diagnostic accuracy and therapeutic decision-making in managing CFA patients.
  • Highlights less common clinical manifestations to aid in broader recognition of the disease spectrum.